FDA

Latest Stories

In this Jan. 8, 2021, file photo, a pharmacist prepares a syringe of the Pfizer vaccine for COVID-19, at Queen Anne Healthcare, a skilled nursing and rehabilitation facility in Seattle. The U.S. vaccination drive against COVID-19 stood on the verge of a major new phase as government advisers Thursday, Sept. 23, recommended booster doses of Pfizer's vaccine for millions of older or otherwise vulnerable Americans despite doubts the extra shots will do much to slow the pandemic. (AP Photo/Ted S. Warren, File)

CDC panel backs COVID-19 boosters for seniors, those with underlying conditions

By Shen Wu Tan and Tom Howell Jr. - The Washington Times

In this Sept. 14, 2021, file photo, a syringe is prepared with the Pfizer COVID-19 vaccine at a clinic at the Reading Area Community College in Reading, Pa. An influential panel of advisers to the Centers for Disease Control and Prevention met on Wednesday, Sept. 22, to decide who should get COVID-19 booster shots and when. (AP Photo/Matt Rourke)

FDA backs Pfizer COVID-19 boosters for seniors, high-risk persons

By Tom Howell Jr. - The Washington Times

In this April 13, 2021, file photo, a box of Johnson & Johnson vaccines are shown by pharmacist Zsolt Szenasi at a warehouse of Hungaropharma, a Hungarian pharmaceutical wholesale company, in Budapest, Hungary. Johnson & Johnson released data showing that a booster dose to its one-shot coronavirus vaccine provides a strong immune response months after people receive a first dose. (Szilard Koszticsak/MTI via AP) ** FILE **

‘Jack up the stock’: Vaccine profit PR flusters scientists, inflates public expectations

By Tom Howell Jr. - The Washington Times

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, testifies before the Senate Health, Education, Labor, and Pensions Committee hearing, Tuesday, July 20, 2021, on Capitol Hill in Washington. (Stefani Reynolds/The New York Times via AP, Pool)

‘Story is not over’: Fauci, others say booster push is just starting

By Tom Howell Jr. and Shen Wu Tan - The Washington Times

In this March 2, 2021, photo, Hollie Maloney, a pharmacy technician, loads a syringe with Pfizer's COVID-19 vaccine at the Portland Expo in Portland, Maine. (AP Photo/Robert F. Bukaty) ** FILE **

FDA advisory panel rejects COVID-19 booster shots for most Americans

By Shen Wu Tan - The Washington Times

In this Sept. 14, 2021, photo, a syringe is prepared with the Pfizer COVID-19 vaccine at a clinic at the Reading Area Community College in Reading, Pa. President Joe Biden has directed OSHA to write a rule requiring employers with at least 100 workers to force employees to get vaccinated or produce weekly test results showing they are virus free.(AP Photo/Matt Rourke) **FILE**

Biden careful not to play favorites, but Pfizer enjoys some ‘comparative advantage’ in mandate era

By Tom Howell Jr. - The Washington Times

In this Aug. 26, 2021, photo, Parsia Jahanbani prepares a syringe with the Pfizer COVID-19 vaccine in a mobile vaccine clinic operated by Families Together of Orange County in Santa Ana, Calif. An international group of scientists is arguing the average person doesn't need a COVID-19 booster yet — an opinion that highlights the intense scientific divide over the question. (AP Photo/Jae C. Hong) **FILE**

Crunch time for Biden’s booster plan as key health panels convene

By Tom Howell Jr. - The Washington Times

FILE - In this Tuesday, May 11, 2021 file photo, Dr. Peter Marks, director of the Center for Biologics Evaluation and Research in the Food and Drug Administration, testifies during a Senate health, education, labor, and pensions hearing to examine an update from federal officials on efforts to combat COVID-19 on Capitol Hill in Washington. On Friday, Sept. 10, 2021, Marks urged parents to be patient, saying the agency will rapidly evaluate vaccines for 5- to 11-year-olds as soon as it gets the needed data. (Jim Lo Scalzo/Pool via AP)

FDA official hopeful younger kids can get shots this year

By Lauran Neergaard - Associated Press

FDA rejects almost 1 million flavored e-cigarette, vaping products, orders removed from market

By Shen Wu Tan - The Washington Times

FILE - This Jan. 29, 2021, file photo shows the packaging and a container of veterinary ivermectin in Johannesburg, South Africa. Ivermectin, which is produced by a number of drugmakers in various countries, has been used throughout the world for decades to treat infections of parasites in humans and some large animals. Health experts and medical groups are pushing to stamp out the growing use of the drug to treat COVID-19, warning that it can cause harmful side effects and there’s little evidence it helps. (AP Photo/Denis Farrell, File)

Health officials: Choose safer COVID options than ivermectin

By Dave Kolpack - Associated Press

In this file photo, Dr. Anthony Fauci testifies before the Senate Health, Education, Labor, and Pensions Committee, on Capitol Hill in Washington, Tuesday, July 20, 2021. (AP Photo/J. Scott Applewhite, Pool) ** FILE **

Fauci optimistic about Pfizer booster shot approval by Sept. 20

By Seth McLaughlin - The Washington Times

In this file photo, Dr. Anthony Fauci testifies before the Senate Health, Education, Labor, and Pensions Committee, on Capitol Hill in Washington, Tuesday, July 20, 2021. (AP Photo/J. Scott Applewhite, Pool) ** FILE **

Dr. Fauci: Three-dose program could become standard for COVID-19 vaccine

By Tom Howell Jr. - The Washington Times

Rep. Louie Gohmert, R-Texas, discusses the infrastructure bill making its way through Congress during a news conference held by the House Freedom Caucus on Capitol Hill in Washington, Monday, Aug. 23, 2021. (AP Photo/Amanda Andrade-Rhoades) **FILE**

Rep. Louis Gohmert touts ivermectin as COVID-19 treatment contrary to warnings from CDC, FDA

By Andrew Blake - The Washington Times

People sit under a Delta sign at Salt Lake City International Airport on July 1, 2021, in Salt Lake City. Delta Air Lines won't force employees to get vaccinated, but it's going to make unvaccinated workers pay a $200 monthly charge. Delta said Wednesday, Aug. 25, 2021 that it will also require weekly testing for unvaccinated employees starting next month, although the airline says it'll pick up the cost of that testing. (AP Photo/Rick Bowmer, File)

Get the shot or else: Corporate America, health companies put teeth behind vaccine mandates

By Tom Howell Jr. - The Washington Times

In this file photo, U.S. Army medic Kristen Rogers of Waxhaw, N.C. fills syringes with the Johnson & Johnson COVID-19 vaccine, Wednesday, March 3, 2021, in North Miami, Fla. (AP Photo/Marta Lavandier) **FILE**

Pentagon orders COVID-19 vaccinations for military personnel

By Mike Glenn - The Washington Times

In this Feb. 9, 2021, file photo provided by the Department of Defense, Hickam 15th Medical Group hosts the first COVID-19 mass vaccination on Joint Base Pearl Harbor-Hickam. Military service members must immediately begin to get the COVID-19 vaccine, Defense Secretary Lloyd Austin said in a memo Wednesday, Aug. 25, 2021, ordering service leaders to “impose ambitious timelines for implementation.” (U.S. Air Force Tech. Sgt. Anthony Nelson Jr./Department of Defense via AP)

Pentagon: U.S. troops must get their COVID-19 vaccines ASAP

By Lolita C. Baldor - Associated Press

In this March 2, 2021, photo, pharmacy technician Hollie Maloney loads a syringe with Pfizer's COVID-19 vaccine at the Portland Expo in Portland, Maine. The U.S. gave full approval to Pfizer's COVID-19 vaccine on Monday, Aug. 23, 2021. (AP Photo/Robert F. Bukaty) **FILE**

Pfizer vaccine’s FDA approval creates new hurdle for anti-mandate lawsuits

By Alex Swoyer - The Washington Times

In this March 2, 2021, photo, pharmacy technician Hollie Maloney loads a syringe with Pfizer's COVID-19 vaccine at the Portland Expo in Portland, Maine. The U.S. gave full approval to Pfizer's COVID-19 vaccine on Monday, Aug. 23, 2021. (AP Photo/Robert F. Bukaty) **FILE**

FDA fully approves Pfizer-BioNTech COVID-19 shot; major step should spur vaccinations, mandates

By Tom Howell Jr. - The Washington Times

FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Several U.S. senators are questioning the Food and Drug Administration’s work with a consulting firm that helped businesses sell prescription painkillers during the nation's overdose crisis. Democrat Maggie Hassan of New Hampshire and Republican Chuck Grassley of Iowa, among others, have asked the FDA about potential conflicts of interest in its work with McKinsey and Co. The senators sent a letter Monday, Aug. 23, 2021 to the FDA noting that the agency paid McKinsey more than $140 million after hiring it several times starting in 2008. (AP Photo/Toby Talbot, file)

Senators question FDA on work with opioid maker consultant

By Tom Murphy - Associated Press

President Joe Biden delivers remarks on the full FDA approval of the Pfizer-BioNTech coronavirus vaccine, in the South Court Auditorium on the White House campus, Monday, Aug. 23, 2021, in Washington. (AP Photo/Evan Vucci)

Biden: More employers should mandate COVID-19 vaccination

By Tom Howell Jr. - The Washington Times